We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Diabetes & Endocrinology

Produce Prescription for Diabetes Falls Short in Improving Health Outcomes

MedXY Editorial Team•Apr 21, 2026•Diabetes & Endocrinology
diabetesProduce Prescriptionrandomized trialThiếu an ninh lương thực

Background

Food insecurity is a significant barrier to effective diabetes management, as it limits access to nutritious foods necessary for glycemic control. Patients with diabetes who experience food insecurity are at higher risk for poor health outcomes, including uncontrolled blood sugar and increased healthcare utilization. Despite the recognized need for interventions that address food insecurity, evidence on the effectiveness of produce prescription programs remains limited.

Study Design

This pragmatic randomized clinical trial enrolled 2155 patients with diabetes at risk for food insecurity from an integrated academic health system in the southeastern US. Participants were randomly assigned to either a produce prescription (PRx) group, receiving a $80 monthly debit card for fruits, vegetables, and legumes, or a usual care group. Both groups received diabetes self-management educational materials. The primary outcomes were changes in HbA1c levels and emergency department visits at 12 months.

Key Findings

The study found no significant improvement in HbA1c levels among participants in the PRx group compared to usual care, with an adjusted difference of just 0.20 percentage points (95% CI, 0.05%-0.35%) favoring usual care. There were also no significant differences in secondary outcomes, including body mass index, blood pressure, or inpatient visits. Subgroup analysis of participants with elevated HbA1c (≥8%) similarly showed no benefit.

Expert Commentary

“While produce prescriptions are a well-intentioned strategy, this study suggests that financial subsidies alone may not be sufficient to improve cardiometabolic health in high-risk diabetic patients,” noted Dr. Michael Pignone, a co-author of the study. The moderate utilization of the benefit—only 30% of participants used 80% or more of the monthly allowance—highlights potential barriers such as transportation or cooking skills that may limit the program’s effectiveness.

Conclusion

This trial demonstrates that a produce prescription subsidy, without additional support, does not significantly improve health outcomes in diabetic patients at risk for food insecurity. Future interventions may need to incorporate more comprehensive approaches, including nutrition education and addressing systemic barriers to healthy food access.

Funding and Trial Registration

This study was supported by the National Institutes of Health and registered on ClinicalTrials.gov (NCT05896644).

References

Drake C, et al. JAMA Intern Med. 2026;186(4):416-424. PMID: 41697676.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

The Central Role of Guilt in Daily Diabetes-Specific Emotional Burdens: Insights from Intensive Longitudinal Network AnalysisThis study highlights how daily feelings of guilt are central drivers of negative emotional burdens in diabetes, influencing emotional well-being and risk of distress and depression.Sep 25, 2026From Alert to Action: Enhancing Diabetes Self-Management Referrals Through Electronic Health Record AlertsA cluster-randomized trial demonstrates that integrating best practice advisories (BPAs) and standing orders into electronic health records significantly improves referral rates to diabetes self-management education and support (DSMES) overSep 21, 2026Mortality and Morbidity After Below-Knee Amputation in Diabetes: Insights from a 25-Year English Cohort StudyThis large-scale England study reveals persistently high mortality after below-knee amputation in diabetes, with one-year mortality exceeding 23%, emphasizing the need for targeted interventions focused on older, female, and comorbid patienSep 17, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Global Trends in the Burden of Ischemic Stroke Attributable to Diabetes Versus Atrial Fibrillation
This study analyzes global trends comparing ischemic stroke burdens linked to diabetes and atrial fibrillation, revealing a rising impact of diabetes-related stroke and highlighting the need for targeted interventions.
Sep 12, 2026
Charcot Neuro-Osteoarthropathy in Diabetes: High Risk of Hospitalization, Amputation, and Mortality Revealed by Regional Cohort StudyCharcot neuro-osteoarthropathy (CNO) in people with diabetes is linked to frequent emergency hospitalizations, substantial risk of limb amputation, and reduced survival, highlighting urgent need for intensified multidisciplinary care.Sep 5, 2026
Bridging the Gap: Ensuring Outpatient Follow-Up After Emergency Department Visits for DiabetesLess than half of diabetes patients discharged from the emergency department receive timely outpatient follow-up, underscoring critical care continuity gaps that require targeted interventions to improve outcomes.Sep 1, 2026